When men come to Dr. J Anti-Aging Clinic, the first question I try to answer before recommending any treatment is: what’s actually causing this?
Erectile dysfunction is a symptom, not a disease. The underlying cause determines the right treatment and for the majority of men over 40, that underlying cause is vascular. Understanding why helps you understand what regenerative treatments like the MENZ Tox Shot™, MENZ Wave®, and MENZ Shot™ are actually targeting.
What Vasculogenic ED Is
Vasculogenic erectile dysfunction is ED caused by impaired blood flow to the penis specifically, dysfunction in the vascular and endothelial tissue of the corpus cavernosum, the paired erectile chambers that fill with blood during an erection.
A healthy erection requires three things to happen in rapid sequence: sexual arousal triggers nitric oxide (NO) release from endothelial cells lining penile arteries; NO signals smooth muscle in those arterial walls to relax; relaxed arterial smooth muscle allows blood to flow in under pressure, filling the corpus cavernosum; and rising intracavernosal pressure compresses venous outflow, maintaining rigidity. Break any link in that chain, and the erection fails.
Vasculogenic ED breaks the first two links most commonly: reduced nitric oxide availability (due to endothelial dysfunction) and impaired arterial smooth muscle relaxation (due to smooth muscle fibrosis and elevated sympathetic tone). The result is insufficient arterial inflow, inadequate filling, and a failure to trap blood at pressure.
Why It Develops The Risk Factor Picture
The conditions that damage penile vascular tissue are the same conditions that damage vascular tissue everywhere in the body. Vasculogenic ED is, at its root, a manifestation of cardiovascular and metabolic disease at a particularly sensitive vascular bed.
Diabetes mellitus: Advanced glycation end-products damage endothelial cells, impair nitric oxide synthase activity, and accelerate smooth muscle fibrosis. ED is often the first clinical sign of diabetes-related vascular damage.
Hypertension: Chronic elevated pressure damages arterial walls and impairs endothelial function. Antihypertensive medications particularly beta-blockers and thiazide diuretics can also impair erectile function as a side effect.
Dyslipidemia: Elevated LDL and reduced HDL contribute to atherosclerotic changes in penile arteries, reducing arterial compliance and blood flow capacity.
Smoking: Directly impairs endothelial NO production and accelerates vascular aging. Smoking-related ED is among the most severe in terms of Doppler ultrasound findings.
Age: Normal aging involves progressive reduction in penile smooth muscle mass, declining testosterone, and reduced endothelial NO bioavailability even in metabolically healthy men.
How Vasculogenic ED Is Diagnosed
A clinical history is the starting point the pattern of onset (gradual vs. sudden), presence of morning erections, response to PDE5 inhibitors, and cardiovascular risk factor profile all give important diagnostic information. Penile Doppler ultrasound measuring peak systolic velocity (PSV) and end-diastolic velocity (EDV) of penile arteries is the gold-standard imaging test when objective confirmation of vascular impairment is needed.
A PSV below 25 cm/s after pharmacologically-induced erection indicates arterial insufficiency. Many of the men enrolled in RCTs of MENZ Tox Shot™ and MENZ Wave® had pre-treatment Doppler measurements confirming vasculogenic impairment, and post-treatment Doppler improvements provided objective evidence of vascular restoration.
What Regenerative Treatments Are Targeting
Now that the mechanism is clear, the rationale for each MENZ treatment follows naturally.
MENZ Wave® builds new blood vessels (neovascularization) and restores endothelial nitric oxide production directly addressing the two primary vascular defects of vasculogenic ED.
MENZ Shot™ delivers PRP growth factors that repair smooth muscle cells and endothelial lining addressing the tissue damage that reduces the corpus cavernosum’s capacity to fill and trap blood.
MENZ Tox Shot™ reduces sympathetic smooth muscle constriction addressing the neurogenic vascular resistance that opposes blood flow even in partially repaired vasculature. The El-Shaer 2021 RCT showed post-treatment improvements in peak systolic velocity on Doppler ultrasound an objective vascular measurement confirming that the functional improvement was real, not just subjective.
El-Shaer et al., Andrology, 2021. PMID: 33784020
- Dr. J:
Vasculogenic ED is not a willpower problem or a psychological failing. It’s a vascular disease the same underlying process that puts men at risk for cardiovascular events. I take it seriously on those terms, and I treat it on those terms.
A Note on Treating the Whole Problem
Managing cardiovascular risk factors blood sugar, blood pressure, lipids, smoking cessation, physical activity is not optional for men with vasculogenic ED who want meaningful long-term improvement. Regenerative treatments can restore vascular function meaningfully. But if the forces that caused the damage continue unchecked, the regenerated tissue will face the same degradation over time. The clinical conversation includes both the treatment and the foundation it needs to work on.
▸ READY TO TALK TO DR. J?
If you’re experiencing ED that developed gradually and has progressed despite medication, a physician evaluation at Dr. J Anti-Aging Clinic can determine whether vasculogenic dysfunction is driving it and what targeted treatment makes sense.
Call/Text: (407) 972-1197 | drjantiagingclinic.com